Lilly says Mounjaro and Zepbound sales grew by at least 110% as stock rallies

Lilly says Mounjaro and Zepbound sales more than doubled as stock rallies - MarketWatch# Lilly says Mounjaro and Zepbound sales more than doubled as stock rallies## The drugmaker also detailed strong growth for 2026Last Updated: Feb. 4, 2026 at 7:32 a.m. ETFirst Published: Feb. 4, 2026 at 7:21 a.m. ETShareResize--- Listen(3 min)Eli Lilly said its fourth-quarter sales grew by 43% to $19.3 billion, surpassing the FactSet estimate of $17.9 billion. Photo: Getty ImagesEli Lilly's stock soared 7% in premarket tr ...